.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Accenture
QuintilesIMS
Fish and Richardson
Healthtrust
Moodys
Chinese Patent Office
Covington
Harvard Business School
Chubb

Generated: September 22, 2017

DrugPatentWatch Database Preview

Enalapril maleate; felodipine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for enalapril maleate; felodipine and what is the scope of enalapril maleate; felodipine patent protection?

Enalapril maleate; felodipine
is the generic ingredient in one branded drug marketed by Astrazeneca and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for enalapril maleate; felodipine.

Summary for Generic Name: enalapril maleate; felodipine

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list27
Bulk Api Vendors: see list1
Clinical Trials: see list292
Patent Applications: see list9
Drug Prices:see low prices
DailyMed Link:enalapril maleate; felodipine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enalapril maleate; felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-001Dec 27, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Moodys
Harvard Business School
Colorcon
Mallinckrodt
US Army
Federal Trade Commission
Dow
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot